Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | TELA TELA Bio, Inc. | 13D/A | 9.9% | Jun 28, 2024 | 2y |
| Apex Holdco L.P. | VERY Vericity, Inc. Common Stock | 13D/A | 0% | Jun 28, 2024 | 2y |
| Ara K. Hovnanian | HOV Hovnanian Enterprises Inc | 13D/A | 15.2% | Jun 28, 2024 | 2y |
| GKCC, LLC | ELTX Elicio Therapeutics, Inc. | 13D/A | 19.99% | Jun 28, 2024 | 2y |
| Headlands Capital Management, LLC | NDLS NOODLES & Co | 13D/A | 9.5% | Jun 28, 2024 | 2y |
| Deutsche Telekom AG | TMUS T-Mobile US, Inc. | 13D/A | 57% | Jun 28, 2024 | 2y |
| Pinetree Capital Ltd. | TBRG TruBridge, Inc. | 13D/A | 10.8% | Jun 28, 2024 | 2y |
| Keith A. Hutton | TXO TXO Partners, L.P. | 13D | 10.4% | Jun 28, 2024 | 2y |
| DGP Co., Ltd. | XCUR Exicure, Inc. | 13D/A | 35.4% | Jun 28, 2024 | 2y |
| A. Lorne Weil | INSE Inspired Entertainment, Inc. | 13D/A | 9.9% | Jun 28, 2024 | 2y |
| Hawk Acquisition, Inc. | INVE INVE Technologies, Inc. | 13D/A | 0% | Jun 28, 2024 | 2y |
| CAS Investment Partners, LLC | CDLX Cardlytics, Inc. | 13D/A | 13.2% | Jun 28, 2024 | 2y |
| Joe Lewis | INSG Inseego Corp. | 13D/A | 16.7% | Jun 28, 2024 | 2y |
| Divisadero Street Capital Management, LP | DAVE Dave Inc. | 13G | 5.9% | Jun 27, 2024 | 2y |
| Robert Forster | CNSP CNS Pharmaceuticals, Inc. | 13G | 0% | Jun 27, 2024 | 2y |
| Deep Track Capital, LP | CLYM Climb Bio, Inc. | 13G | 5.85% | Jun 27, 2024 | 2y |
| ROGER M. KLEIN | AGRX Agile Therapeutics, Inc | 13G | 9% | Jun 26, 2024 | 2y |
| Millennium Management LLC | ZIMV ZimVie Inc. Common Stock | 13G | 4.7% | Jun 25, 2024 | 2y |
| F. Hurst Lin (“Lin”) | GCT GigaCloud Technology Inc | 13D/A | 13.8% | Jun 24, 2024 | 2y |
| Alumni Capital LP | KZIA Kazia Therapeutics Ltd | 13G | 9.99% | Jun 18, 2024 | 2y |
| Decus Pro OU | FCCN SPECTRAL CAPITAL Corp | 13D | 41.83% | Jan 27, 2022 | 2y |
| Leonard M. Tannenbaum | AFCG Advanced Flower Capital Inc. | 13D/A | 27.5% | Jan 11, 2022 | 2y |
| Liang Meng | HOLI Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island) | 13D/A | 13.7% | Jul 1, 2024 | 2y |
| Advent International, L.P. | CCC CCC Intelligent Solutions Holdings Inc. | 13D/A | 22.4% | Jul 1, 2024 | 2y |
| Louis A. DeNaples | FNCB FNCB Bancorp Inc. Common Stock | 13D/A | 0% | Jul 1, 2024 | 2y |
| CoyCo GP, L.L.C. | RCM R1 RCM Inc. Common Stock | 13D/A | 32.3% | Jul 1, 2024 | 2y |
| OH Cypress Aggregator, L.P. | CCC CCC Intelligent Solutions Holdings Inc. | 13D/A | 4.5% | Jul 1, 2024 | 2y |
| GAMCO INVESTORS, INC. ET AL | CUTR Cutera, Inc. | 13D/A | 2.48% | Jun 28, 2024 | 2y |
| Legion Partners Asset Management, LLC | LFCR Lifecore Biomedical, Inc. De | 13D/A | 15.2% | Jun 28, 2024 | 2y |
| 22NW Fund, LP | LFCR Lifecore Biomedical, Inc. De | 13D/A | 12.4% | Jun 28, 2024 | 2y |
| Irrevocable Larson Family Investment Trust | RMTI Rockwell Medical, Inc. | 13G/A | 8.5% | Jun 28, 2024 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | CLYM Climb Bio, Inc. | 13D/A | 47.1% | Jun 27, 2024 | 2y |
| Mitsui Sumitomo Insurance Co Ltd | HIPO Hippo Holdings Inc. | 13D/A | 4.46% | Jun 27, 2024 | 2y |
| Ernest C. Garcia II | CVNA Carvana Co. | 13D/A | 41.1% | Jun 27, 2024 | 2y |
| MILLENNIUM MANAGEMENT LLC | MED Medifast Inc | 13G | 4.3% | Jun 27, 2024 | 2y |
| LAWRENCE SANDS | VSEE Vsee Health, Inc. | 13D | 25.96% | Jun 24, 2024 | 2y |
| IMOIGELE P. AISIKU | VSEE Vsee Health, Inc. | 13D | 24.07% | Jun 24, 2024 | 2y |
| MILTON CHEN | VSEE Vsee Health, Inc. | 13D | 19.53% | Jun 24, 2024 | 2y |
| Keith Gill | CHWY Chewy, Inc. | 13G | 6.6% | Jun 24, 2024 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | PRAX Praxis Precision Medicines, Inc. | 13G | 7.2% | Jun 21, 2024 | 2y |
| EcoR1 Capital, LLC | TECX Tectonic Therapeutic, Inc. | 13G | 5.8% | Jun 20, 2024 | 2y |
| Patrick E. Paddon Irrevocable Trust 2024 | CFNB California First Leasing Corp | 13G | 14% | Jun 4, 2024 | 2y |
| Mr. G.V. Prasad N/A | RDY Dr Reddys Laboratories Ltd | 13D/A | 13.04% | May 22, 2024 | 2y |
| Radcliffe Capital Management, L.P. | CPTKW Crown PropTech Acquisitions | 13G/A | 0% | Jun 28, 2024 | 2y |
| Ionic Ventures, LLC | BBLG Bone Biologics Corp | 13G/A | 3.8% | Jun 28, 2024 | 2y |
| Radcliffe Capital Management, L.P. | VMCAF Valuence Merger Corp. I | 13G/A | 0% | Jun 28, 2024 | 2y |
| Radcliffe Capital Management, L.P. | CDAQF Compass Digital Acquisition Corp. | 13G/A | 0% | Jun 28, 2024 | 2y |
| Radcliffe Capital Management, L.P. | ANGX Angel Studios, Inc. | 13G/A | 0% | Jun 28, 2024 | 2y |
| Radcliffe Capital Management, L.P. | TWOA two | 13G/A | 0% | Jun 28, 2024 | 2y |
| Ionic Ventures, LLC | GROM Grom Social Enterprises Inc. Common Stock | 13G/A | 1.8% | Jun 28, 2024 | 2y |